Can AI replace humans in pharmacovigilance?

Let's continue the conversation started at  the World Safety Conference in Boston

Date: April 10, 2025 

Time: 10:00-11:00AM US EST / 4:00-5:00 PM CEST

Register Now

About the webinar

In October 2024, we hosted a roundtable discussion on artificial intelligence (AI) in pharmacovigilance (PV) at the World Safety Conference in Boston. The session sparked insightful conversations and drew a strong audience of delegates eager to participate or listen.

During the discussion, we explored the benefits of AI, such as reducing data entry errors, saving time when creating cases in safety databases, and improving accuracy in listings and summary tabulations. We also addressed key challenges, including software costs, data security concerns, programming errors, and the lack of specific regulations governing AI use in pharmacovigilance.

Unfortunately, time ran out before we could cover everything. However, many attendees expressed a strong interest in continuing the conversation—so that’s exactly what we’ll be doing in this upcoming webinar roundtable discussion!

What we'll discuss

  • The benefits of AI in PV, expanding on the conference discussion
  • The challenges of AI in PV, expanding on the conference discussion
  • The current regulations related to the use of AI in PV

Unable to join? Register and you will receive the recording after the live session.

Meet the host

  • Angie Robertson Bio Photo

    Angie Robertson

    Director, Systems and Submissions

    View Bio

Angie Robertson is an experienced pharmacovigilance subject matter expert with over 23 years’ experience in the pharmacovigilance space. Starting out as a nurse, then moving on to clinical research coordinator, Angie has experienced the clinical side of drug, device and vaccine safety and efficacy.

Learning end to end safety data collection and case processing led to a passion for database configuration and analytics solutions.

Angie’s practical and creative problem-solving skills have contributed to many successful safety data migrations and vendor transitions using Argus and ArisG in a pharmaceutical company setting as well as a CRO.